OVID
Ovid Therapeutics Inc
NASDAQ: OVID · HEALTHCARE · BIOTECHNOLOGY
$2.69
-0.37% today
Updated 2026-04-29
Market cap
$465.47M
P/E ratio
—
P/S ratio
64.19x
EPS (TTM)
$-0.23
Dividend yield
—
52W range
$0 – $3
Volume
3.4M
Ovid Therapeutics Inc (OVID) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |